MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-11-0013033
Sarika Life Sciences Private Limited
Sarika Life Sciences Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.89 Cr
▲ 77% YoY
Net profit · FY 2025
₹25.47 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹44.09 Lakh
EBITDA margin 3.7%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Open charges
₹5 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
About Sarika Life Sciences Private Limited
Data last updated:
Sarika Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC320129. Its GSTIN is 07AAYCS8962L1Z4 (Delhi).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹15 Lakh. It is led by directors Saksham Sabharwal and Sanchita Sabharwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 234 2nd Floor Vishal Tower District Centre Janak Puri, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.89 Cr, a growth of 77% compared to the previous year. For the same year it recorded a net profit of ₹25.47 Lakh (net margin 2.1%) and EBITDA of ₹44.09 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 55% over five years.
As per MCA filings, the company has open charges of ₹5 Cr on record.
Sarika Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0013033). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999DL2017PTC320129
Registration Number 320129
Incorporation Date 04 July 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-11-0013033
Recognitions & Rankings of Sarika Life Sciences
Contact details
Sarika Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address234 2nd Floor Vishal Tower District Centre Janak Puri, New Delhi, Delhi, India – 110058
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sarika Life Sciences Private Limited, buy the company report.
Comprehensive company report
Sarika Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sarika Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sarika Life Sciences Private Limited, buy the company report.
Financials of Sarika Life Sciences Private Limited
FY 2025 filings availableSarika Life Sciences Private Limited reported revenue of ₹11.89 Cr (up 77% YoY) for FY 2025.
Revenue · FY 2025
₹11.89 Cr ▲ 77%
Net profit · FY 2025
₹25.47 Lakh margin 2.1%
EBITDA · FY 2025
₹44.09 Lakh margin 3.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 77%
3 years · compounded
▼ 8%
5 years · compounded
▲ 55%
EBITDA CAGR growth
1 year
▲ 34%
3 years · compounded
▼ 63%
5 years · compounded
▲ 61%
Revenue has grown at a compounded annual rate (CAGR) of 55% over five years, including 77% growth in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹44.09 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹25.47 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.7% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sarika Life Sciences Private Limited, buy the company report.
Board of directors of Sarika Life Sciences Private Limited
Sarika Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saksham Sabharwal | Director | 27 Jul 2021 | 5 Years 2 Months | Current |
| Sanchita Sabharwal | Director | 04 Jul 2017 | 9 Years 3 Months | Current |
Peer comparison
Sarika Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| M R G Consultants Private Limited | ₹11.9 Cr (FY 2025) | -7.0% | Ghaziabad, Uttar Pradesh, India | |||
| Aste Enterprises Private Limited | ₹11.9 Cr (FY 2025) | -47.0% | New Delhi, Delhi, India | |||
| SB Composites Private Limited | ₹11.9 Cr (FY 2024) | 17.0% | Chennai, Tamil Nadu, India | |||
| M K Mobiles Private Limited | ₹11.9 Cr (FY 2025) | -10.0% | Hyderabad, Telangana, India | |||
| Filsilpek Solutions Private Limited | ₹11.9 Cr (FY 2024) | 53.0% | Ahmedabad, Gujarat, India | |||
| Sarika Life Sciences Private Limited this company | ₹11.89 Cr (FY 2025) | ₹25.47 Lakh | 2.1% | 77.0% | New Delhi, Delhi, India | |
| Geodigital Media Private Limited | ₹11.89 Cr (FY 2024) | 29.0% | Delhi, India | |||
| Jayniaa Corporation Private Limited | ₹11.89 Cr (FY 2025) | 433.0% | Ahmedabad, Gujarat, India | |||
| Vyoma Decors Private Limited | ₹11.89 Cr (FY 2024) | 59.0% | Delhi, India | |||
| S.N. Biri Factory Private Limited | ₹11.89 Cr (FY 2025) | 29.0% | Murshidabad, West Bengal, India | |||
| Raj Pal Agro India Private Limited | ₹11.89 Cr (FY 2022) | 12.0% | Faridkot, Punjab, India |
To see the full peer comparison of Sarika Life Sciences Private Limited, buy the company report.
Auditor
Sarika Life Sciences Private Limited is audited by J S SACHDEVA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J S SACHDEVA & CO | FY 2019 | 017415N |
Shareholding
The shareholding of Sarika Life Sciences Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Sarika Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Apr 2024 | 100908419 | Others | ₹5 Cr | Open |
To see the full charge records of Sarika Life Sciences Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sarika Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sarika Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sarika Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAYCS8962L1Z4 | Delhi | Active | 19 Oct 2017 |
To see the full GST registrations and return filing status of Sarika Life Sciences Private Limited, buy the company report.
Recent activity
Sarika Life Sciences Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Saksham Sabharwal ceased to be Additional Director on 29 Nov 2021.
AGM
Sarika Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sarika Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Others of Rs. 5.00 Cr registered on 20 Apr 2024 with Charge ID 100908419 was modified on 25 Mar 2025.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100908419 was registered on 20 Apr 2024.
Ceased
Saksham Sabharwal ceased to be Additional Director.
Ceased
Sarika Sabharwal ceased to be Director.
Appointed
Saksham Sabharwal was appointed as Director.
Appointed
Sanchita Sabharwal was appointed as Director.
Incorporation
04 Jul 2017
Sarika Life Sciences Private Limited was registered on 04 Jul 2017 with Roc Delhi Ii & aged 9 years 3 months as per MCA records.
Frequently asked questions
Sarika Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 July 2017 (9+ years old) and is registered under CIN U74999DL2017PTC320129.
Sarika Life Sciences has 2 current directors:
- Saksham Sabharwal - Director
- Sanchita Sabharwal - Director
The latest financial statements of Sarika Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Sarika Life Sciences is 07AAYCS8962L1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Sarika Life Sciences is U74999DL2017PTC320129. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sarika Life Sciences was incorporated on 04 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sarika Life Sciences by revenue are M R G Consultants Private Limited, Aste Enterprises Private Limited, SB Composites Private Limited, M K Mobiles Private Limited, Filsilpek Solutions Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Saksham Sabharwal ceased to be Additional Director on 29 Nov 2021. Sarika Sabharwal ceased to be Director on 31 Jul 2021. Saksham Sabharwal was appointed as Director on 27 Jul 2021. Sarika Life Sciences has 4 board changes on record in total.
Yes, Sarika Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-DL-11-0013033).
The registered office of Sarika Life Sciences is at 234 2nd Floor Vishal Tower District Centre Janak Puri, New Delhi, Delhi, India – 110058.
Sarika Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.